Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 5.03 is in line with its 5-year average of 4.99, near the low end of its 5-year range (3.58–21.92).
As of the fiscal period ended Tuesday, June 30, 2026. 4.04% above its 12-month average of 4.84.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 5.03.
CURRENT RATIO
5.03
CURRENT RATIO AVG TTM
4.84
CURRENT RATIO AVG 3Y
4.62
CURRENT RATIO AVG 5Y
4.99
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+4.04%
CURRENT VS 3Y AVG
+9.00%
CURRENT VS 5Y AVG
+0.97%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
1.61
median of 98 covered companies
CURRENT VS SECTOR MEDIAN
+212.65%
vs the sector median at left
Recursion Pharmaceuticals, Inc.
Market Cap
$2.14B
Current Ratio
5.03
TTM Avg
4.84
3Y Avg
4.62
5Y Avg
4.99
Market Cap
$1.72B
Current Ratio
6.65
TTM Avg
5.42
3Y Avg
7.28
5Y Avg
7.47
Market Cap
$397.55M
Current Ratio
10.71
TTM Avg
7.83
3Y Avg
8.94
5Y Avg
8.94
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Recursion Pharmaceuticals, Inc. (RXRX) | $2.14B | 5.03 | 4.84 | 4.62 | 4.99 |
| Beam Therapeutics Inc. (BEAM)vs › | $2.51B | 14.57 | 8.96 | 7.17 | 6.28 |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.73B | 1.63 | 1.31 | 1.40 | 1.40 |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.72B | 6.65 | 5.42 | 7.28 | 7.47 |
| TransMedics Group, Inc. (TMDX)vs › | $2.74B | 6.62 | 7.72 | 8.85 | 8.81 |
| Teladoc Health, Inc. (TDOC)vs › | $1.00B | 0.83 | 2.23 | 2.80 | 3.02 |
| NeoGenomics, Inc. (NEO)vs › | $472.39M | 3.60 | 3.12 | 4.79 | 5.52 |
| NRC Health (NRC)vs › | $459.30M | 0.65 | 0.55 | 0.77 | 1.10 |
| Shoulder Innovations, Inc. (SI)vs › | $397.55M | 10.71 | 7.83 | 8.94 | 8.94 |
| PDS Biotechnology Corporation (PDSB)vs › | $41.03M | 0.57 | 2.81 | 4.44 | 7.47 |
Current Ratio
5.03
Quick Ratio
5.03
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 5.03 |
| 2026-03-31 | 5.47 |
| 2025-12-31 | 5.50 |
| 2025-09-30 | 4.60 |
| 2025-06-30 | 3.58 |
| 2025-03-31 | 4.11 |
| 2024-12-31 | 3.81 |
| 2024-09-30 | 4.35 |
| 2024-06-30 | 6.07 |
| 2024-03-31 | 4.65 |
| 2023-12-31 | 4.70 |
| 2023-09-30 | 4.36 |
| 2023-06-30 | 3.78 |
| 2023-03-31 | 5.34 |
| 2022-12-31 | 5.68 |
| 2022-09-30 | 5.80 |
| 2022-06-30 | 5.65 |
| 2022-03-31 | 7.23 |
| 2021-12-31 | 11.46 |
| 2021-09-30 | 13.99 |
| 2021-06-30 | 21.92 |
| 2021-03-31 | 8.26 |
| 2020-12-31 | 11.53 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
